Fulgent Genetics, Inc. (FLGT) shareholders
Close on Nov 17, 2026Market cap $666.15MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Ming Hsieh Joint filing with The Ming Hsieh Trust (28.72%) | 8,872,539 | 32.26% | 13D (active) amendment | May 22, 2026 |
| Barclays PLC | 2,338,451 | 7.57% | 13G (passive) amendment | Mar 31, 2025 |
| BlackRock, Inc. | 1,819,823 | 5.90% | 13G (passive) amendment | Mar 31, 2025 |
| Millennium Management LLC Joint filing with Millennium Group Management LLC (5.60%), Israel A. Englander (5.60%) and 1 more | 1,691,811 | 5.60% | 13G (passive) amendment | Jul 22, 2025 |
| Ramya Rao | 1,658,059 | 5.42% | 13G (passive) | Dec 31, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of FLGT | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2,286,669 | 8.31% | $46.92M | −487,850 | 0.00% |
| Acadian Asset Management LLC | 1,017,913 | 3.70% | $20.87M | −216,038 | 0.02% |
| Vanguard Capital Management LLC | 789,498 | 2.87% | $16.20M | −90,652 | 0.00% |
| Jacobs Levy Equity Management, Inc | 782,116 | 2.84% | $16.05M | +425,757 | 0.06% |
| JPMorgan Chase & Co | 756,558 | 2.75% | $15.53M | +296,195 | 0.00% |
| Diametric Capital, LP | 697,784 | 2.54% | $14.32M | +336,738 | 1.51% |
| Ameriprise Financial Inc | 670,084 | 2.44% | $13.75M | +106,709 | 0.00% |
| Dimensional Fund Advisors LP | 625,355 | 2.27% | $12.83M | −46,309 | 0.00% |
| Geode Capital Management, LLC | 521,014 | 1.89% | $10.69M | −63,193 | 0.00% |
| State Street Corp | 498,673 | 1.81% | $10.23M | −30,726 | 0.00% |
| Invenomic Capital Management LP | 498,287 | 1.81% | $10.22M | −112,031 | 0.61% |
| Two Sigma Investments, LP | 400,986 | 1.46% | $8.23M | +78,797 | 0.01% |
| Charles Schwab Investment Management Inc | 350,987 | 1.28% | $7.20M | −3,197 | 0.00% |
| Millennium Management LLC | 320,910 | 1.17% | $6.59M | −80,909 | 0.00% |
| Goldman Sachs Group Inc | 307,940 | 1.12% | $6.32M | −3,483 | 0.00% |
| D. E. Shaw & Co., Inc. | 292,006 | 1.06% | $5.99M | −194,764 | 0.00% |
| Hrt Financial LP | 229,444 | 0.83% | $4.71M | +182,996 | 0.00% |
| Peapod Lane Capital LLC | 224,207 | 0.81% | $4.60M | +3,580 | 3.10% |
| Point72 Asset Management, L.P. | 211,708 | 0.77% | $4.34M | New | 0.00% |
| Medina Value Partners, LLC | 193,061 | 0.70% | $3.96M | +22,992 | 0.78% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 142 | 16M | 57.0% | 21 / 40 | 55 / 36 | 3M | 4M |
| Q1 2026 | 158 | 17M | 63.5% | 29 / 48 | 56 / 46 | 5M | 4M |
| Q4 2025 | 179 | 18M | 65.1% | 34 / 55 | 54 / 14 | 3M | 2M |
| Q3 2025 | 163 | 18M | 63.8% | 19 / 56 | 52 / 22 | 3M | 1M |
| Q2 2025 | 167 | 16M | 59.1% | 20 / 59 | 51 / 27 | 3M | 3M |
| Q1 2025 | 176 | 16M | 59.3% | 26 / 63 | 50 / 36 | 4M | 4M |
| Q4 2024 | 189 | 17M | 61.8% | 31 / 70 | 50 / 25 | 2M | 1M |
| Q3 2024 | 183 | 16M | 59.7% | 33 / 48 | 58 / 22 | 6M | 1M |
| Q2 2024 | 174 | 15M | 56.1% | 30 / 58 | 49 / 34 | 1M | 2M |
| Q1 2024 | 180 | 16M | 56.4% | 25 / 52 | 61 / 39 | 2M | 2M |
| Q4 2023 | 196 | 15M | 54.2% | 28 / 51 | 74 / 31 | 2M | 2M |
| Q3 2023 | 201 | 14M | 51.7% | 21 / 62 | 68 / 31 | 2M | 1M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
167 funds held FLGT in Q2 2026, 46% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of FLGT | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 551,839 | 2.01% | $11.32M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 514,046 | 1.87% | $10.55M | 0.01% | Jun 30, 2026 |
| Columbia Small Cap Value Discovery Fund | 396,579 | 1.44% | $6.56M | 0.26% | Jul 31, 2026 |
| BlackRock Advantage Small Cap Core Fund | 306,170 | 1.11% | $5.55M | 0.11% | May 29, 2026 |
| Invenomic Fund | 262,951 | 0.96% | $4.35M | 0.51% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 217,572 | 0.79% | $4.46M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 212,867 | 0.77% | $3.52M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 178,697 | 0.65% | $3.67M | 0.03% | Jun 30, 2026 |
| Schwab Fundamental U.S. Small Company ETF | 135,029 | 0.49% | $2.45M | 0.03% | May 31, 2026 |
| iShares Biotechnology ETF | 128,918 | 0.47% | $2.65M | 0.03% | Jun 30, 2026 |
| U.S. Small Cap Portfolio | 122,950 | 0.45% | $2.03M | 0.01% | Jul 31, 2026 |
| Fidelity Extended Market Index Fund | 110,018 | 0.40% | $2.00M | 0.00% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 107,764 | 0.39% | $1.95M | 0.01% | May 31, 2026 |
| U.S. Micro Cap Portfolio | 102,809 | 0.37% | $1.70M | 0.02% | Jul 31, 2026 |
| Multi-Manager Small Cap Equity Strategies Fund | 101,496 | 0.37% | $1.84M | 0.14% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Ming Hsieh | Chief Executive Officer, Director, 10% owner | 8,783,067 | 31.92% | Sep 3, 2026 |
| Paul Kim | CFO and Treasurer | 353,795 | 1.29% | Oct 28, 2026 |
| Jian Xie | President and COO | 576,379 | 2.09% | Oct 28, 2026 |
| Hanlin Gao | Chief Scientific Officer | 984,472 | 3.58% | Oct 28, 2026 |
| Michael Nohaile | Director | 24,578 | 0.09% | May 18, 2026 |
| Regina E. Groves | Director | 28,099 | 0.10% | May 18, 2026 |
| Linda Dong | Director | 38,758 | 0.14% | May 18, 2026 |
| Hsieh Trust Ming | 10% owner | 8,760,703 | 31.84% | Mar 31, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Hanlin Gao Chief Scientific Officer | Oct 26, 2026 | Tax withholding | −1,645 | $20.22 | $33.26K | 984,472 |
| Jian Xie President and COO | Oct 26, 2026 | Tax withholding | −4,361 | $20.22 | $88.18K | 355,563 |
| Paul Kim CFO and Treasurer | Oct 26, 2026 | Tax withholding | −2,748 | $20.22 | $55.56K | 353,795 |
| Hanlin Gao Chief Scientific Officer | Sep 2, 2026 | Sale | −1,673 | $19.66 | $32.89K | 986,117 |
| Jian Xie President and COO | Sep 2, 2026 | Sale | −2,127 | $19.66 | $41.82K | 359,924 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | Sep 1, 2026 | Tax withholding | −4,392 | $19.59 | $86.04K | 885,952 |
| Paul Kim CFO and Treasurer | Sep 1, 2026 | Tax withholding | −2,087 | $19.59 | $40.88K | 356,543 |
| Jian Xie President and COO | Aug 27, 2026 | Sale | −1,193 | $19.91 | $23.75K | 362,051 |
| Hanlin Gao Chief Scientific Officer | Aug 27, 2026 | Sale | −939 | $19.91 | $18.70K | 987,790 |
| Paul Kim CFO and Treasurer | Aug 26, 2026 | Tax withholding | −1,168 | $19.81 | $23.14K | 358,630 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | Aug 26, 2026 | Tax withholding | −2,949 | $19.81 | $58.42K | 890,344 |
| Jian Xie President and COO | Jul 26, 2026 | Tax withholding | −4,361 | $19.67 | $85.78K | 363,244 |
| Paul Kim CFO and Treasurer | Jul 26, 2026 | Tax withholding | −2,747 | $19.67 | $54.03K | 359,798 |
| Hanlin Gao Chief Scientific Officer | Jul 26, 2026 | Tax withholding | −1,645 | $19.67 | $32.36K | 988,729 |
| Hanlin Gao Chief Scientific Officer | Jun 2, 2026 | Sale | −1,688 | $17.89 | $30.20K | 990,374 |
| Jian Xie President and COO | Jun 2, 2026 | Sale | −2,146 | $17.89 | $38.39K | 367,605 |
| Paul Kim CFO and Treasurer | Jun 1, 2026 | Tax withholding | −2,087 | $18.09 | $37.75K | 362,545 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | Jun 1, 2026 | Tax withholding | −4,392 | $18.09 | $79.45K | 893,293 |
| Hanlin Gao Chief Scientific Officer | May 27, 2026 | Sale | −945 | $17.60 | $16.63K | 992,062 |
| Jian Xie President and COO | May 27, 2026 | Sale | −1,201 | $17.60 | $21.14K | 369,751 |
| Paul Kim CFO and Treasurer | May 26, 2026 | Tax withholding | −1,168 | $17.67 | $20.64K | 364,632 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | May 26, 2026 | Tax withholding | −2,949 | $17.67 | $52.11K | 897,685 |
| Linda Dong Director | May 14, 2026 | Award | +11,117 | – | – | 38,758 |
| Regina E. Groves Director | May 14, 2026 | Award | +11,117 | – | – | 28,099 |
| Michael Nohaile Director | May 14, 2026 | Award | +5,558 | – | – | 24,578 |
| Jian Xie President and COO | Apr 26, 2026 | Tax withholding | −4,361 | $16.31 | $71.13K | 370,952 |
| Hanlin Gao Chief Scientific Officer | Apr 26, 2026 | Tax withholding | −1,645 | $16.31 | $26.83K | 993,007 |
| Paul Kim CFO and Treasurer | Apr 26, 2026 | Tax withholding | −2,747 | $16.31 | $44.80K | 365,800 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | Mar 1, 2026 | Tax withholding | −17,566 | $15.33 | $269.29K | 900,634 |
| Hanlin Gao Chief Scientific Officer | Mar 1, 2026 | Tax withholding | −6,410 | $15.33 | $98.27K | 994,652 |
| Hanlin Gao Chief Scientific Officer | Mar 1, 2026 | Tax withholding | −1,018 | $15.33 | $15.61K | 1,001,062 |
| Jian Xie President and COO | Mar 1, 2026 | Tax withholding | −1,079 | $15.33 | $16.54K | 383,460 |
| Jian Xie President and COO | Mar 1, 2026 | Tax withholding | −8,147 | $15.33 | $124.89K | 375,313 |
| Paul Kim CFO and Treasurer | Mar 1, 2026 | Tax withholding | −8,347 | $15.33 | $127.96K | 368,547 |
| Paul Kim CFO and Treasurer | Mar 1, 2026 | Tax withholding | −1,133 | $15.33 | $17.37K | 376,894 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | Feb 26, 2026 | Tax withholding | −2,949 | $24.76 | $73.02K | 918,200 |
| Hanlin Gao Chief Scientific Officer | Feb 26, 2026 | Tax withholding | −897 | $24.76 | $22.21K | 1,002,080 |
| Jian Xie President and COO | Feb 26, 2026 | Tax withholding | −1,140 | $24.76 | $28.23K | 384,539 |
| Paul Kim CFO and Treasurer | Feb 26, 2026 | Tax withholding | −1,168 | $24.76 | $28.92K | 378,027 |
| Jian Xie President and COO | Feb 24, 2026 | Award | +5,862 | – | – | 337,245 |
| Jian Xie President and COO | Feb 24, 2026 | Award | +15,299 | – | – | 352,544 |
| Jian Xie President and COO | Feb 24, 2026 | Award | +27,341 | – | – | 379,885 |
| Jian Xie President and COO | Feb 24, 2026 | Tax withholding | −3,163 | $23.09 | $73.03K | 376,722 |
| Jian Xie President and COO | Feb 24, 2026 | Tax withholding | −8,254 | $23.09 | $190.58K | 368,468 |
| Jian Xie President and COO | Feb 24, 2026 | Tax withholding | −14,751 | $23.09 | $340.60K | 353,717 |
| Jian Xie President and COO | Feb 24, 2026 | Award | +31,962 | – | – | 385,679 |
| Hanlin Gao Chief Scientific Officer | Feb 24, 2026 | Tax withholding | −2,489 | $23.09 | $57.47K | 989,126 |
| Hanlin Gao Chief Scientific Officer | Feb 24, 2026 | Award | +22,806 | – | – | 991,615 |
| Hanlin Gao Chief Scientific Officer | Feb 24, 2026 | Award | +12,762 | – | – | 968,809 |
| Hanlin Gao Chief Scientific Officer | Feb 24, 2026 | Award | +4,891 | – | – | 956,047 |
| Hanlin Gao Chief Scientific Officer | Feb 24, 2026 | Award | +26,661 | – | – | 1,002,977 |
| Hanlin Gao Chief Scientific Officer | Feb 24, 2026 | Tax withholding | −8,149 | $23.09 | $188.16K | 976,316 |
| Hanlin Gao Chief Scientific Officer | Feb 24, 2026 | Tax withholding | −4,661 | $23.09 | $107.62K | 984,465 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | Feb 24, 2026 | Award | +69,294 | – | – | 921,149 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | Feb 24, 2026 | Tax withholding | −31,760 | $23.09 | $733.34K | 851,855 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | Feb 24, 2026 | Tax withholding | −21,354 | $23.09 | $493.06K | 883,615 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | Feb 24, 2026 | Tax withholding | −10,230 | $23.09 | $236.21K | 904,969 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | Feb 24, 2026 | Award | +59,276 | – | – | 915,199 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | Feb 24, 2026 | Award | +39,802 | – | – | 855,923 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | Feb 24, 2026 | Award | +19,067 | – | – | 816,121 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Fulgent Genetics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 10,059 shares on Sep 25, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Hanlin Gao Officer | Sep 2, 2026 | 1,673 | $32.89K | Sep 2, 2026 | Restricted stock vest |
| Jian Xie Officer | Sep 2, 2026 | 2,127 | $41.81K | Sep 2, 2026 | Resticted stock vest |
| Jian Xie Officer | Aug 27, 2026 | 1,193 | $23.75K | Aug 27, 2026 | Resticted stock vest |
| Hanlin Gao Officer | Aug 27, 2026 | 939 | $18.69K | Aug 27, 2026 | Restricted stock vest |
| Jian Xie Officer | Jun 2, 2026 | 2,146 | $38.38K | Jun 2, 2026 | Resticted stock vest |
| Hanlin Gao Officer | Dec 1, 2025 | 1,070 | $30.52K | Dec 2, 2025 | Restricted stock vest |
| Jian Xie Officer | Dec 1, 2025 | 1,135 | $32.37K | Dec 2, 2025 | Resticted stock vest |
| Jian Xie Officer | Nov 26, 2025 | 1,198 | $36.12K | Nov 28, 2025 | Resticted stock vest |
| Hanlin Gao Officer | Nov 26, 2025 | 943 | $28.43K | Nov 28, 2025 | Restricted stock vest |
| Hanlin Gao Officer | Nov 24, 2025 | 535 | $16.30K | Nov 24, 2025 | Restricted stock vest |
| Jian Xie Officer | Nov 24, 2025 | 681 | $20.75K | Nov 24, 2025 | Resticted stock vest |
| Jian Xie Officer | Nov 19, 2025 | 20,000 | $580.98K | Nov 19, 2025 | Resticted stock vest |
| Jian Xie Officer | Sep 3, 2025 | 1,128 | $24.85K | Sep 3, 2025 | Resticted stock vest |
| Hanlin Gao Officer | Sep 3, 2025 | 1,063 | $23.41K | Sep 3, 2025 | Restricted stock vest |
| Hanlin Gao Officer | Aug 27, 2025 | 943 | $20.26K | Aug 27, 2025 | Restricted stock vest |
See a number that looks wrong?